Cargando…
Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus
Host-directed therapeutics are a promising anti-infective strategy against intracellular bacterial pathogens. Repurposing host-targeted drugs approved by the FDA in the US, the MHRA in the UK and/or regulatory equivalents in other countries, is particularly interesting because these drugs are commer...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425000/ https://www.ncbi.nlm.nih.gov/pubmed/30890742 http://dx.doi.org/10.1038/s41598-019-41260-8 |